Add to ORKGDepression is a disease that effects millions of patients and has a variety of symptoms. It is primarily defined by depressed mood and anhedonia. The first line treatment for depression is SSRI medications. These medications have several side effects and are not effective for a large number of patients. Therefore, this study was done to review ketamine as a new treatment option for depression and see how it compares to a placebo
Since publication of the first randomized controlled trial describing rapid antidepressant effects o...
Major Depressive Disorder (MDD) is a common psychiatric disorder with major implications for healthc...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...
Over the last few years, ketamine has been studied as a possible treatment option for Major Depressi...
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produ...
Prior studies have reported variously on the presence or absence of dissociative effects at subanest...
Ketamine, via intravenous infusions, has emerged as a novel therapy for treatment-resistant depressi...
Objective: The objective of this selective EBM review is to determine whether or not ketamine is eff...
Background: Depression is a common psychiatric disorder that has become the leading cause of disabil...
Background: Depression is one of the most common mental disorders. Currently used antidepressants, a...
Objective: Narrative review of the literature on the efficacy and safety of subanaesthetic doses of ...
Millions of people around the world suffer from Major Depressive Disorder, and many of these people ...
Background: Major depressive disorder is a severe, heterogeneous, common medical illness and a leadi...
The objective of this thesis was to investigate the safety and efficacy of single and repeated admin...
Ketamine has been used to provide a rapid and persistent antidepressant effect in patients with trea...
Since publication of the first randomized controlled trial describing rapid antidepressant effects o...
Major Depressive Disorder (MDD) is a common psychiatric disorder with major implications for healthc...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...
Over the last few years, ketamine has been studied as a possible treatment option for Major Depressi...
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produ...
Prior studies have reported variously on the presence or absence of dissociative effects at subanest...
Ketamine, via intravenous infusions, has emerged as a novel therapy for treatment-resistant depressi...
Objective: The objective of this selective EBM review is to determine whether or not ketamine is eff...
Background: Depression is a common psychiatric disorder that has become the leading cause of disabil...
Background: Depression is one of the most common mental disorders. Currently used antidepressants, a...
Objective: Narrative review of the literature on the efficacy and safety of subanaesthetic doses of ...
Millions of people around the world suffer from Major Depressive Disorder, and many of these people ...
Background: Major depressive disorder is a severe, heterogeneous, common medical illness and a leadi...
The objective of this thesis was to investigate the safety and efficacy of single and repeated admin...
Ketamine has been used to provide a rapid and persistent antidepressant effect in patients with trea...
Since publication of the first randomized controlled trial describing rapid antidepressant effects o...
Major Depressive Disorder (MDD) is a common psychiatric disorder with major implications for healthc...
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understandi...